US FDA Takes Star Turn In Recent Drug Ingredient Liability Lawsuits
Interjection In Zantac MDL Is Agency's Second In Past Year
Agency’s direct involvement in pharma product liability litigation is one of the most striking developments in the field over the past year; 16 cases in multidistrict litigation listed in chart showing status of settlements and upcoming bellwether trials.
